RecruitingNot ApplicableNCT07352982

Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea

Effect of Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea


Sponsor

Kafrelsheikh University

Enrollment

32 participants

Start Date

Jan 19, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the effects of transcutaneous tibial nerve stimulation (TTNS) on women with primary dysmenorrhea (PD).


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 25 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a nerve stimulation treatment called transcutaneous tibial nerve stimulation (TTNS) — which delivers gentle electrical pulses through the skin near the ankle — to help reduce period pain (primary dysmenorrhea) in young women. This is a non-drug, non-invasive approach to managing menstrual cramps. **You may be eligible if:** - You are between 20 and 25 years old - You have a BMI of 30 or below - A gynecologist has diagnosed you with primary dysmenorrhea (period pain with no underlying condition) - You have regular menstrual cycles - You experience pain in the lower abdomen, lower back, or upper thighs during at least half of your periods or in the last 3 cycles **You may NOT be eligible if:** - You have a diagnosed gynecological condition (e.g., endometriosis, fibroids) - You use oral contraceptives or have an intrauterine device (IUD) - You have a bleeding disorder, cancer, severe mental illness, or nerve problems in your legs - You smoke or take oral sedatives - You have had surgery or given birth in the last 6 months - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTranscutaneous tibial nerve stimulation (TTNS)

Patients will receive the transcutaneous tibial nerve stimulation (TTNS) and traditional treatment (Nonsteroidal anti-inflammatory drugs) for three sessions a week for four consecutive weeks.

DRUGTraditional treatment (Nonsteroidal anti-inflammatory drugs)

Patients will receive the placebo transcutaneous tibial nerve stimulation (TTNS) and traditional treatment (Nonsteroidal anti-inflammatory drugs) for three sessions a week for four consecutive weeks.


Locations(1)

Kafrelsheikh University (Faculty of Physical Therapy)

Kafr ash Shaykh, Kafrelsheikh, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07352982


Related Trials